Purchase Order HHSD2002017M92822P
- Not listed
- This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
- This federal contract award is for laboratory equipment and supplies provided by Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, with a ceiling value of $27,785.90, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of June 17, 2016. This award is not associated with a set-aside program....
- The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
- This federal contract award was made by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the purchase of scientific consumables, such as DNA/RNA extraction kits, next-generation sequencing equipment, and bioinformatics software, with a ceiling value of $6,162.64. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Qiagen's ability to compete effectively in the federal...
- This federal contract award was issued by the Headquarters Division of the Department of Justice (DOJ) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $100,000.00 firm fixed-price purchase order contract provides for the delivery of Qiagen's products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen has held several indefinite delivery contracts (IDCs) and...
- This federal contract award is for Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V., to provide 6 DNeasy 96 Plant Kits to a U.S. government agency for $8,970.78. The contract has a firm-fixed price and an ultimate completion date of July 27, 2015. Qiagen is an experienced federal contractor, holding multiple indefinite delivery vehicles (IDVs) with agencies such as the Department of Veterans Affairs, Defense Health Agency, and Federal Bureau of Investigation to...
- This is a federal contract award to QIAGEN LLC, a subsidiary of the international biotechnology company QIAGEN N.V., by a civilian federal agency, the Office of the Chief Operating Officer. The $3,135.48 firm fixed-price contract is a blanket purchase agreement (BPA) call order to provide molecular diagnostics products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools,...
- This federal contract award is for QIAGEN TEST KITS AND OTHER ANCILLARIES FOR THE CT HCS (Contract ID: VA24115D0168|36C24119N0016) with a ceiling value of $98,582.70. The award was made on October 1, 2018 to Qiagen, LLC, a subsidiary of Qiagen N.V., a multinational biotechnology company that provides sample and assay technologies to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This appears to be a delivery order under a larger indefinite...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
This federal contract award to Qiagen, LLC, a subsidiary of the international provider Qiagen N.V., has a ceiling value of $180,000.00. The award is for "OTHER FUNCTIONS" and was made on December 29, 2016, with an ultimate completion date of December 28, 2019. The contract is a Firm Fixed Price Purchase Order without a Set-Aside designation. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, and bioinformatics software. The company holds several federal Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements to deliver these specialized products and services efficiently to customers such as the Army, VA, and Defense Health Agency. This particular award does not appear to be associated with a larger contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Exercise an Option | $56.0k | 11/6/18 | |
| 1 | Exercise an Option | $56.0k | 11/16/17 | |
| Not listed | Not listed | $68.0k | 1/8/17 |